Inventor

Csaba J. Peto

Inventor
Alameda, CA, US

Overview

22→
Patents
1998–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 22 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes25%
C07HSugars2%
PatentTitleYear
11,072,600Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer202110,640,493Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer202010,562,886Anti-cancer compounds202010,266,518Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof20199,796,704'Substituted quinazolines as receptor-type kinase inhibitors'20179,359,332'Processes for the preparation of substituted quinazolines'20169,163,006'Processes for the preparation of substituted quinazolines'20158,697,737'Raf modulators and methods of use'20148,658,654'Receptor-type kinase modulators and methods of use'20148,648,066'Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture'20148,637,499'Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture'20148,372,851'Pyrazolo pyrimidines as casein kinase II (CK2) modulators'20138,362,002'Azetidines as MEK inhibitors for the treatment of proliferative diseases'20138,101,625'Pyrimidinones as Casein Kinase II (CK2) modulators'20128,012,956'Tropane compounds'20117,915,250'Azetidines as MEK inhibitors for the treatment of proliferative diseases'20117,872,014'Anaplastic lymphoma kinase modulators and methods of use'20117,846,959'Raf modulators and methods of use'20107,803,839'Azetidines as MEK inhibitors for the treatment of proliferative diseases'20107,704,995'Protein kinase modulators and methods of use'20107,576,074'Receptor-type kinase modulators and methods of use'20095,849,709'Saccharopeptides and derivatives thereof'1998

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1998–2019Based in Alameda, CA, US· patent location history
2009–2014Patents assigned to BUSSENIUS JOERG (8)· patent assignee history
2009–2014Patents assigned to PETO CSABA J (8)· patent assignee history
2009–2014Patents assigned to RICE KENNETH D (8)· patent assignee history
2009–2014Patents assigned to TSANG TSZE H (7)· patent assignee history
2010–2014Patents assigned to EXELIXIS INC (12)· patent assignee history
2020–2021Based in San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EXELIXIS INC122010–2014
BUSSENIUS JOERG82009–2014
PETO CSABA Jself82009–2014
RICE KENNETH D82009–2014
TSANG TSZE H72009–2014
Locations
LocationPatentsSpan
Alameda, California, US191998–2019
San Francisco, California, US32020–2021